ePrivacy and GPDR Cookie Consent by TermsFeed Generator

DULSEVIA

60MG CPS ETD 30

Maximum ex-factory price/Ex-factory price ? 426,32 CZK
Legal basis of maximum ex-factory price/ex-factory price ? Maximum ex-factory price announced under the law.

Informace o základní úhradě

Core reimbursement from health insurance ? 408,66 CZK
Maximum reimbursement from health insurance ? 601,90 CZK
Legal basis of reimbursement from health insurance ? Reimbursement set by the law.
Indication restriction of reimbursement ? Duloxetin je předepisován k léčbě diabetické neuropatické bolesti u pacientů, kteří neměli dostatečnou terapeutickou odpověď (nedošlo ke zmírnění bolesti alespoň o 50% dle VAS) nebo netolerovali léky první volby (amitriptylin, karbamazepin). Kontrola účinnosti léčby duloxetinem v této indikaci je provedena nejpozději po 6 týdnech a pokud nedošlo k dostatečné terapeutické odpovědi, není léčba dále indikována.
Prescribing doctor's specialisation ? Neurology, children's neurology
Diabetology
Algesiology, palliative care
Reporting limit ? E: Unless it is advisable to transfer the prescription of the product to another doctor under paragraph 2 in light of the effect and safety of the product, the "E" symbol will mark the product in the decision.
Rough price for the final consumer ? 617,80 CZK
Rough payment for the final consumer (for 1 prescribed package dispensed) ? 15.9 CZK
Eligible extra payment ?
Eligible extra payment for individuals aged 65 and older ?
Medicinal products reimbursed from health insurance contain the amount of the maximum manufacturer´s price or the producer´s notified price for products which are not subjected to the regulation of the maximum manufacturer´s price, the amount of reimbursement from health insurance and the estimated price for the end consumer (pharmacy price).

Back to list